https://www.intelliatx.com/resources/joint-statement-of-position-regarding-human-germline-gene-editing-dec-2015/ 2020-10-06T18:37:12+00:00 https://www.intelliatx.com/resources/what-are-genome-editing-and-crispr-cas9/ 2020-10-06T18:38:13+00:00 https://www.intelliatx.com/resources/crispr-guide/ 2020-10-06T18:38:47+00:00 https://www.intelliatx.com/resources/the-future-of-therapeutic-genome-editing-in-european-healthcare-systems/ 2020-10-06T18:39:33+00:00 https://www.intelliatx.com/resources/human-genome-editing-science-ethics-and-governance/ 2020-10-06T18:40:36+00:00 https://www.intelliatx.com/resources/the-promise-of-human-genome-editing-for-rare-and-genetic-disease/ 2020-10-06T18:41:47+00:00 https://www.intelliatx.com/resources/chief-medical-officer-annual-report-2016-generation-genome/ 2020-10-06T18:43:20+00:00 https://www.intelliatx.com/resources/car-t-cells-engineering-patients-immune-cells-to-treat-their-cancers/ 2020-10-06T18:44:07+00:00 https://www.intelliatx.com/resources/the-nobel-prize-in-chemistry-2020/ 2020-10-07T13:42:54+00:00 https://www.intelliatx.com/resources/test-link-with-video/ 2020-10-07T16:21:55+00:00 https://www.intelliatx.com/resources/ntla-2001-and-transthyretin-attr-amyloidosis-fact-sheet/ 2021-06-26T17:11:47+00:00